Sustainability & Climate

Japanese pharma giant Meiji Seika Pharma backs Centivax's quest for a universal flu vaccine, a move that could revolutionize global pandemic preparedness.

After promising results in a key patient subgroup, the PREVAiLS study will test if pridopidine can slow the relentless progression of ALS.

Doble Engineering's new handheld Spark P2 detector promises to revolutionize power grid maintenance with its portability and user-friendly advanced diagnostics.

Neumora reveals promising data for Alzheimer's and schizophrenia drugs, but a delay in its obesity program highlights the high-stakes world of biotech.

As millions grapple with Cannabis Use Disorder, a small biotech's lead drug enters Phase 3 trials, promising the first-ever FDA-approved treatment.

Forget thread count. The future of bedding is about microclimate regulation, certified safety, and sustainable materials. See how PHF is leading the charge.

As Q1 results loom, the gold giant is expected to post strong figures amid high prices. Investors are watching its cash pile, costs, and hybrid AGM.

Analyses reveal the EPA allows pesticides with high cancer risks on the market without warning labels, raising major public health and legal questions.

Newly-listed Blossom Gold hires a top IR exec, pursues a US dual listing, and launches a massive drilling program to fast-track its Nevada gold project.

Japanese innovator Tenchijin joins a top French accelerator, bringing its satellite-AI tech to tackle Europe's aging and leaky water infrastructure.

FoodTrack is ditching calorie counting, blending AI with Traditional Chinese wellness to offer personalized health insights from photos of your meals, face, and tongue.

Beijing hails Xizang's economic boom, but critics point to a deep erosion of culture and rights. What is the true story of development on the roof of the world?

Highstar launches China's first overseas tabless battery factory in Malaysia, unveiling a high-performance cell for tools, robots, and future eVTOLs.

Swedish tech firm JLT leverages 30 years of industrial rugged computing to enter the defense market, aligning with national security and EU autonomy goals.

A new functional beverage with 500mg of Ashwagandha enters the UK, aiming to capture the growing market for mindful, non-alcoholic drink options.

Top execs from Hyundai, dealer associations, and policy groups will debate the future of EVs, trade, and affordability at a critical new NYIAS panel.

Chinese pet platform Boqii slashes losses by 75% despite falling revenue, betting its future on high-margin private labels and operational discipline.

Kansas City gets a taste of 2026 glory as the FIFA World Cup Trophy Tour arrives, kicking off a countdown to the world's biggest sporting event.

With a fortified balance sheet and promising clinical data, Monopar Therapeutics is advancing its lead drug, ALXN1840, toward a pivotal NDA filing.

Beyond roller coasters, a Japanese city is tackling demographic decline with English lessons and multicultural festivals to build a future chosen by the world.